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Autophagy and the DNA damage response (DDR) are biological processes essential
for cellular and organismal homeostasis. Herein, we summarize and discuss emerging
evidence linking DDR to autophagy. We highlight published data suggesting that
autophagy is activated by DNA damage and is required for several functional outcomes
of DDR signaling, including repair of DNA lesions, senescence, cell death, and cytokine
secretion. Uncovering the mechanisms by which autophagy and DDR are intertwined
provides novel insight into the pathobiology of conditions associated with accumulation
of DNA damage, including cancer and aging, and novel concepts for the development
of improved therapeutic strategies against these pathologies.
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THE DNA DAMAGE RESPONSE
The term ‘DNA damage response’ (DDR) refers to a network of intracellular pathways that sense
and resolve damaged DNA. If unrepaired, DNA lesions may result in cell death (Roos et al., 2016)
but can also be a major source of genomic instability particularly when cell death pathways have
been deactivated (Halazonetis et al., 2008). DDR signaling has been extensively reviewed elsewhere
(Halazonetis et al., 2008; Jackson and Bartek, 2009; Marechal and Zou, 2013; Ribezzo et al., 2016);
below we provide a summary of some of its components and their functions which are most
relevant to this review.
Abbreviations: AMPK, AMP-kinase; AP1, activator protein 1; APC, antigen-presenting cells; ATM, ataxia-telangiectasia
mutated; ATR, ATM- and Rad3-Related; BASC, BRCA1-associated genome surveillance complex; CMA, chaperone-
mediated autophagy; Chk1/Chk2, Checkpoint kinases 1/2; DAMP, damage-associated molecular pattern; DAPK, death-
associated protein kinase; DDB, damage specific DNA binding proteins 1 and 2; DNA-PK, DNA-dependent protein
kinase; DRAM, damage-regulated autophagy modulator; FOXO3, Forkhead box O3; GATA4, GATA Binding Protein 4;
HDAC, histone deacetylases; HMGB1, High Mobility Group Box 1; HP1α, heterochromatin protein 1α; HR, homologous
recombination; IKKγ, inhibitor of nuclear factor kappa-B kinase subunit gamma; JNK, cJun N-terminal kinase; LC3,
microtubule-associated protein light chain 3; MRN, Mre11-Rad50-Nbs1 complex; mtDNA, mitochondrial DNA; NEMO,
NF-κB essential modulator; NER, nucleotide excision repair; NHEJ, non-homologous end joining; PI3K, phosphatidylinositol
3-kinase; PINK1, PTEN-induced putative kinase 1; PTEN, Phosphatase and Tensin homolog; RAG, Ras-related GTPases;
SASP, senescence-associated secretory phenotype; SQSTM1, sequestosome 1; TAK1, transforming growth factor beta-
activated kinase 1; TASCC, TOR-Autophagy Spatial Coupling Compartment; TORC1, mechanistic target of rapamycin
complex 1; TRAF3IP2, TNF receptor–associated factor interacting protein 2; TSC2, Tuberous Sclerosis Complex 2; ULK1,
unc-51-like autophagy-activating kinase 1; UVRAG, UV radiation resistance-associated gene; XPA, xeroderma pigmentosum
group A; XPC, xeroderma pigmentosum, complementation group C.
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DNA damage response utilizes proteins involved in sensing,
signaling, and repair of DNA damage. While the early activation
events that follow DNA breaks are well elucidated, the primary
signal which triggers DDR remains incompletely understood. It
has, however, been proposed that when a DNA lesion occurs,
it is accompanied by relaxation of chromatin through a series
of post-translational histone modifications that include poly-
(ADP-ribosylation) which is catalyzed by poly (ADP-ribose)
polymerases (PARPs), phosphorylation and acetylation (Lukas
et al., 2011). These chromatin responses “freeze” transcription
and replication around the site of DNA lesion to facilitate
subsequent repair. They also provide access to DDR sensors
such as the Mre11–Rad50–Nbs1 (MRN) complex which binds
double strand breaks (DSBs) and recruits ATM kinase (Figure 1)
and the replication protein A (RPA) complex which responds
predominantly to single strand DNA lesions and recruits ATR
kinase. The binding of these kinases to damaged DNA triggers
the recruitment of additional proteins, many of which become
phosphorylated and activated to further transduce signals that
orchestrate DNA replication, cell cycle control, transcription,
repair of damage, and/or survival versus death.
Thus, ATM bound to DSBs in conjunction with the MRN
complex, undergoes autophosphorylation and activation. In turn,
ATM activates various downstream effector proteins (Marechal
and Zou, 2013), including Chk2 and Chk1 involved in cell cycle
control, the tumor suppressor p53 which regulates cell survival
versus death, HDAC1 and HDAC2 which are responsible for
chromatin remodeling (Kim et al., 1999), the BASC complex
containing DNA damage repair proteins (Wang et al., 2000),
the senescence regulator ARF (Velimezi et al., 2013) and
transcription factors such as FOXO3 which regulates genes
involved in DNA repair (Tran et al., 2002). ATR shares at
least some of these ATM functions, for example capacity to
phosphorylate p53 and Chk1 in response to irradiation (Liu et al.,
2000; Zhao and Piwnica-Worms, 2001).
In addition to the aforementioned phosphorylation targets,
ATM forms a nuclear complex with PARP1 and NEMO
(also known as IKKγ). Within this complex, NEMO is
subjected to a series of post-translational modifications including
phosphorylation, SUMOylation and ubiquitination that lead to
its nuclear export (Mabb et al., 2006; Wu et al., 2006). Once in the
cytoplasm, NEMO orchestrates the formation of a high molecular
weight multiprotein complex which includes the kinases TAK1,
IKKα, and IKKβ which are responsible for a signaling cascade
that leads to translocation of cytoplasmic RelA NF-κB to the
nucleus. Thus, ATM links DNA damage to NF-κB activation
(Figure 1).
TAK1 also engages the JNK pathway which activates various
transcription factors, including AP1. NF-κB and AP1 transcribe
genes involved in cytokine synthesis and, depending on the
duration of activation, cell survival versus death. Moreover,
ATM utilizes JNK to coordinate optimal p53 activation. Thus,
on one hand, ATM directly phosphorylates p53 at Ser15 which
reduces its affinity for the ubiquitin ligase HDM2 leading to
p53 stabilization. However, ATM also impacts on p53 indirectly
through activation of JNK which phosphorylates p53 at Thr81
enhancing its transcriptional activity (Buschmann et al., 2001)
(Figure 1). DNA damage has been reported to activate JNK also
through the transcriptional repression of the JNK phosphatase
MKP1 caused by transcription-blocking DNA lesions (Hamdi
et al., 2005). Further studies are needed to establish the relative
contribution of the ATM-NEMO-TAK1 versus MKP1 pathways
to JNK activation which is likely to depend on the extent of DNA
damage.
A major end-point of DDR is the activation of the DNA
damage repair system. Depending on the type of damage and the
phase of the cell cycle, different repair mechanisms are utilized
to restore DNA integrity (Jackson and Bartek, 2009; Ribezzo
et al., 2016). For example, PARP1 is involved in the repair of
single strand DNA breaks by recruiting enzymes necessary for
base excision repair such as XRCC1, polymerase β and DNA
ligase III to the sites of damage (de Murcia et al., 1997). DSBs
are mainly repaired by HR, an error-proof process operating
predominantly in the S and G2 phases of the cell cycle, and by
NHEJ which is operational in all phases of the cell cycle but
is error-prone because of the lack of appropriate undamaged
DNA template (Lieber et al., 2003). In general, ATM/ATR-
mediated DDR signaling regulates repair by: (a) inducing the
transcription of DNA-repair genes, (b) modulating DNA-repair
protein activity through post-translational modifications such
as phosphorylation, acetylation, ubiquitination or SUMOylation,
and (c) by recruiting repair factors to the DNA lesion. If the
damage cannot be resolved, chronic DDR signaling triggers cell
death or senescence (Roos et al., 2016).
In addition to nuclear DNA, mtDNA is subject to damage
following exposure to radiation or chemotherapy. Moreover, a
by-product of oxidative production of ATP is the generation
of reactive oxygen species (ROS) which may damage both
mitochondrial and nuclear DNA (Sedelnikova et al., 2010;
Cline, 2012). MtDNA lacks histones which makes it even
more susceptible to injury than nuclear DNA. To counteract
mtDNA damage, mitochondria possess quality control systems
that include antioxidant enzymes and a dedicated repair system
which appears to be less elaborate and effective than the nuclear
DNA damage repair machinery (LeDoux et al., 1992; Cline, 2012).
AUTOPHAGY: GENERAL MECHANISMS
Autophagy is a cellular ‘self-eating’ degradation process in which
proteins or whole organelles are degraded in lysosomes and
recycled to meet the anabolic and bioenergetic needs of the cell.
As such, it plays a pivotal role in tissue homeostasis and various
human pathologies, including cancer, neurodegeneration,
autoimmunity and aging, have been associated with deregulated
autophagy (Mizushima et al., 2008).
Depending on the mechanism of delivery of the cargo to
the lysosomes, three main types of autophagy have been so-far
recognized: micro-autophagy that involves the direct delivery of
cargo to lysosomes through lysosomal membrane invaginations;
CMA which is typified by the lysosomal import of proteins
through their interaction with specialized chaperones; and
macro-autophagy which is the most widely studied mechanism
of autophagy. In macro-autophagy (hereafter termed autophagy),
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FIGURE 1 | Schematic representation of some of the known pathways linking DDR to autophagy. In response to DNA damage, ATM is autophosphorylated
within a MRN multiprotein complex that binds DSBs. Activated ATM initiates a pathway that results in activation of AMPK and its target TSC2 which functions as
inhibitor of TORC1. As ULK1-dependent autophagosome formation is negatively regulated by TORC1, this ATM pathway induces autophagy. In addition, ATM
directly phosphorylates and stabilizes p53 which transcriptionally regulates various regulators of the autophagic pathway including AMPK, DAPK and PTEN.
Sestrins, which are regulated by p53, influence TORC1 activity in an AMPK-dependent and AMPK-independent manner, the latter through a
GATOR2-GATOR1-RAGB/A signaling pathway (see text for details). The ATM-mediated phosphorylation and activation of the RNA polymerase II-binding protein
Che-1, leads to increased transcription of two mTOR inhibitors, Redd1 and Deptor. ATM contributes to the activation of a NEMO-dependent
TAK1-ATM-NEMO-NFκB pathway that transcriptionally modulates Beclin-1. TAK1 may also mediate activation of JNK which in turn phosphorylates Beclin-1 and
releases it from the inhibitory effect of BCL-2 or BCL-XL. DNA damage also blocks transcription of the JNK phosphatase MKP-1, releasing its inhibitory effect over
JNK which in turn induces autophagy. PARP1 activation in response to DNA damage leads to reduction in both NAD+ and ATP pools, with the latter causing
activation of AMPK and induction of autophagy. The DDR-autophagy axis has major implications for DNA damage repair, senescence, cell survival versus death,
cytokine secretion and modulation of the immune response (see text for details). Black arrows (↑) and perpendicular lines (⊥) denote activation and suppression,
respectively. Red arrows denote transcriptional regulation.
the cargo is sequestered in double membrane vesicles known
as autophagosomes, which are progressively formed by the
finely interconnected activities of around 15 autophagy-related
(ATG) proteins (Rubinsztein et al., 2012; Wirth et al., 2013).
Autophagosomes can engulf cytoplasmic material, protein
aggregates, organelles including mitochondria (mitophagy),
peroxisomes (pexophagy) and lipid droplets (lipophagy), as well
as ribosomes (ribophagy) and parts of the nucleus (nucleophagy).
Autophagosome biogenesis entails three steps: initiation,
nucleation, and elongation. Initiation requires the activation
of a complex containing ULK1, ATG13, the FAK-interacting
protein FIP200 and ATG101. Following activation of this ULK
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complex, additional proteins are recruited to form an initial
double membrane structure called the phagophore. This step
requires Vps34 class III PI3K that operates within a progressively
formed large macromolecular “nucleation” complex involving
Beclin-1, ATG14, and Vps15. Subsequent vesicle elongation
allows engulfment and sequestration of organelles or bulk
cytosolic material. The elongation step is driven by the covalent
conjugation of ATG12 to ATG5, supported by ATG7 and
ATG10, and is responsible for the end product of a second
reaction, the conjugation of phosphatidylethanolamine (PE) to
the microtubule-associated protein light chain 3 (LC3). PE-
conjugated (“lipidated”) LC3, known as LC3-II, decorates mature
autophagosomes which are targeted to lysosomes together
with their cargo. The complete process of autophagy from
nucleation to degradation is referred to as autophagic flux
and reflects the actual ability of autophagosomes to degrade
intracellular components. Autophagic flux can be monitored by
determining the degradation of specific autophagic substrates
such as SQSTM1 (also known as p62) which interacts with LC3-
II (Ichimura et al., 2008). SQSTM1/p62 has attracted significant
attention also because of its role in facilitating the degradation
of Lys63-ubiquitinated, p62-sequestered proteins by autophagy
(Pankiv et al., 2007) and its ability to interact with several key
components of the NF-κB pathway (Moscat and Diaz-Meco,
2012).
Phagophore formation is typically triggered by the interaction
of ATG family proteins with two major regulatory complexes,
TORC1 and AMPK. Under nutrient-rich conditions, high
TORC1 activity prevents ULK1 activation by phosphorylating
ULK1 at Ser757 and disrupting the interaction between ULK1
and its activating kinase AMPK (Figure 1) (Alexander et al.,
2010a,b; Kim et al., 2011). Under starvation conditions, AMPK
is activated and induces autophagy by phosphorylating ULK1
at Ser317 and Ser777 and by activating TSC2 thereby inhibiting
TORC1 (Ganley et al., 2009; Laplante and Sabatini, 2012). Recent
studies identified an additional, AMPK-independent mechanism
of TORC1 inhibition that entails Sestrins, the RAG GTPases and a
multiprotein complex called GATOR (GTPase-activating protein
activity toward RAGs) composed of two complexes, GATOR1
and GATOR2. GATOR1 plays an essential role in switching off
TORC1 upon amino acid depletion by functioning as a GAP
for the RAGA/B heterodimer, incapacitating it from interacting
with TORC1. GATOR2 is required for lysosomal recruitment of
TORC1 by amino acids and is a negative regulator for GATOR1
by inhibiting its GAP activity. The interaction of Sestrins with
GATOR2 under nutrient starvation liberates GATOR1 from
GATOR2-mediated inhibition (Figure 1). Released GATOR1
subsequently binds to and inactivates RAGA/B, resulting in
TORC1 suppression (Kim et al., 2015). Among various amino
acids, cytoplasmic leucine was found to bind to Sestrins with the
highest affinity and to disrupt their interaction with GATOR2
leading to TORC1 activation (Wolfson et al., 2016). Arginine,
on the other hand, does not utilize Sestrins but a complex
called CASTOR to release GATOR1 from GATOR2-mediated
inhibition (Chantranupong et al., 2016). Therefore, different
amino acid sensors are involved in TORC1 regulation and, by
inference, on autophagy activation.
However, it should be noted that in addition to the
aforementioned “canonical” pathway of autophagy, alternative
mechanisms of autophagosome formation that do not require the
hierarchical participation of all ATG proteins have been described
and represent an area of intense investigations (Codogno
et al., 2012). For example, unlike amino acid starvation,
autophagy induced by deprivation of glucose or inhibition of
glucose metabolism does not require ULK1 (Cheong et al.,
2011). The topoisomerase inhibitor and clinically relevant
chemotherapeutic agent etoposide induces non-canonical
autophagosome formation that depends on ULK1 and Beclin
but not ATG5, ATG7 or LC3-II (Nishida et al., 2009). Moreover,
basal autophagy under nutrient rich conditions operates in an
ATG5-independent manner and lipidation of LC3 depends on
ATG3 following its conjugation to ATG12 (Murrow et al., 2015).
There is, therefore, a remarkable plasticity in autophagy-
related pathways which is likely to be influenced by the type
of autophagic stimulus and the expression levels of autophagy
regulators. For example, the anti-apoptotic proteins BCL-2 and
BCL-XL which are over-expressed in certain lymphomas and
carcinomas (Eliopoulos et al., 1995), prevent the induction of
autophagy by binding to and inhibiting Beclin-1 (Pattingre
et al., 2005). PTEN antagonizes the effects of the PI3K/AKT
pathway on TORC1 and thus, positively regulates autophagy
(Arico et al., 2001). Conversely, inactivation of PTEN which
occurs with high frequency in certain tumor types, may suppress
autophagic responses through the concomitant constitutive
activation of the PI3K/AKT pathway. The nuclear protein
HMGB1 can induce autophagy in a cell-intrinsic manner
following its translocation to the cytoplasm and interaction with
Beclin-1 to facilitate autophagosome formation (Tang et al.,
2010b). However, HMGB1 is also released extracellularly during
‘immunogenic’ cell death (Kepp et al., 2014), and functions in
conjunction with other DAMP molecules to induce autophagy
in neighboring tumor cells (Tang et al., 2010a). MicroRNA
expression may also influence the autophagic process by targeting
various autophagy pathway components (Zhai et al., 2013).
DDR SIGNALING ACTIVATES
AUTOPHAGY
Accumulating evidence suggests that autophagy can be activated
by DNA damage (Robert et al., 2011; Orlotti et al., 2012; Eapen
and Haber, 2013) through various, albeit not exclusive routes,
summarized in Figure 1.
As described above, ATM is a major sensor of DSBs induced
by genotoxic stress. ATM links DDR to the induction of
autophagy by activating AMPK which in turn phosphorylates
TSC2 and removes the inhibitory effect of TORC1 on autophagy
(Alexander et al., 2010a,b). The aforementioned ATM-AMPK-
TSC2-mediated suppression of TORC1 operates in response to
oxidative and nitrosative stress (Alexander et al., 2010a; Tripathi
et al., 2013), both of which induce DNA damage and may involve
mobilization of ATM to the cytoplasm (Alexander et al., 2010a).
AMPK can also activate ULK1 to promote autophagosome
formation (Kim et al., 2011).
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PARP1, a NAD+ dependent chromatin-associated enzyme
involved in base-excision repair of small adducts such as those
induced by alkylating agents and ROS, is another DDR protein
involved in autophagy regulation (de Murcia et al., 1997). DNA
damage-induced PARP1 activation is associated with a reduction
in both the NAD+ and the ATP pool. The latter is paralleled
by elevated AMP levels that are sensed by AMPK leading to its
activation and induction of autophagy (Rodriguez-Vargas et al.,
2012). DNA damage may induce autophagy also through JNK.
JNK phosphorylates BCL-2 leading to its displacement from
the Beclin-1 complex that primes autophagosomal membrane
formation (Wei et al., 2008).
Whereas the rapid induction of autophagy is mediated
by post-translational modifications such as phosphorylation,
ubiquitination, acetylation and lipidation, the regulation of
autophagy may also depend on the execution of particular
transcriptional and post-transcriptional programs. Indeed, the
β1 and β2 subunits of AMPK are transcriptionally regulated
by p53 (Feng et al., 2007) and are indirectly activated by
p53 through Sestrin1 and Sestrin2 (Budanov and Karin, 2008).
The recent discovery of the Sestrin2-GATOR-RAG pathway
regulating TORC1 raises the possibility that the effects of
p53 on TORC1 may be influenced by leucine availability.
Additionally, p53 up-regulates PTEN expression leading to
TORC1 inactivation (Stambolic et al., 2001; Feng et al., 2007).
Moreover, DAPK, a transcriptional target of p53, triggers
autophagy by phosphorylating Beclin-1 on Thr119 thereby
releasing it from BCL-2 and BCL-XL, and by phosphorylating
protein kinase D (PKD), both of which result in Vps34 class
III PI3K complex activation and autophagy initiation (Zalckvar
et al., 2009a,b; Eisenberg-Lerner and Kimchi, 2012). Another
relevant transcriptional target of p53 is the gene encoding
DRAM, a lysosomal protein that facilitates the end-stage of the
autophagic process (Crighton et al., 2006). However, it should
be noted that unlike its nuclear counterpart, cytoplasmic p53
has been associated with activation of mTOR and repression of
autophagy but the underlying mechanism remains unclear at
present (Tasdemir et al., 2008).
P53 is not the only DDR pathway protein that may
transcriptionally regulate autophagy components (Pietrocola
et al., 2013). For example, tumor protein p63 isoform 1Np63α
which is phosphorylated by ATM in response to genotoxic
stress, transactivates various autophagy regulators including
ULK1, ATG3, ATG5, Beclin-1, ATG7, and ATG10 (Huang
et al., 2012). The same study showed that phosphorylated
1Np63α also modulates the expression levels of ATG5, Beclin-
1, ATG10, ATG12, ATG16L1, and UVRAG indirectly through
the up-regulation of miR-181a, miR-519a, miR-374a, and
miR-630, underscoring the contribution of post-transcriptional
mechanisms to DNA damage-induced autophagy (Zhai et al.,
2013). ATM also mediates the phosphorylation and activation
of Che-1, a RNA polymerase II-binding protein which acts
to increase the transcription of two mTOR inhibitor genes,
Redd1 and Deptor (Desantis et al., 2015). Interestingly, Che-1
expression correlates with the progression of multiple myeloma, a
malignancy characterized by high autophagy responses (Desantis
et al., 2015). Another example of DDR-mediated transcriptional
regulation of autophagy is provided by NF-κB which is activated
by ATM-emanating signals and reported to transcriptionally
upregulate Beclin-1 (Copetti et al., 2009).
As mentioned above, mtDNA is also subject to damage
by irradiation, chemotherapy or ROS. If the extent of this
damage exceeds the capacity of the mitochondrial quality
control mechanisms, a form of autophagy is activated termed
‘mitophagy’ that leads to the lysosomal degradation of the
damaged mitochondria. A critical regulator of this pathway is
PINK1 which acts as sensor for mitochondrial damage. PINK1 is
physiologically imported to the inner mitochondrial membrane;
however, in response to stress-induced loss of mitochondrial
membrane potential, PINK1 fails to be imported and is
instead retained at the outer mitochondrial membrane where it
phosphorylates a number of substrates. One of its targets is the
ubiquitin ligase Parkin which catalyzes Lys63 and Lys48-linked
ubiquitination of outer mitochondrial membrane proteins.
Lys48-linked ubiquitination of target proteins results in their
proteasomal degradation whereas Lys63-linked ubiquitination
leads to recruitment of autophagy adaptors such as optineurin
(OPT), nuclear dot protein 52 (NDP52) and SQSTM1/p62,
which serve as a bridge for the assembly of the ULK1
complex and autophagosome formation (Youle and Narendra,
2011). The entire mitochondrion eventually becomes engulfed
in the autophagosome which then fuses with a lysosome.
This autophagy pathway ensures a healthy mitochondrial pool
which is essential for normal energy metabolism and cellular
homeostasis.
An interesting connection between nuclear DDR signaling
and induction of mitophagy has been reported (Fang et al., 2014,
2016). It has been shown that nuclear DNA damage repair defects
in xeroderma pigmentosum group A (XPA), ataxia-telangiectasia
(AT), or Cockayne syndrome (CS) patients lead to defective
mitophagy and the accumulation of dysfunctional mitochondria
producing damaging levels of ROS (Fang et al., 2014). In
this pathway, systemic DNA damage causes hyperactivation
of PARP1 accompanied by NAD+ depletion and functional
impairment of other NAD+-dependent enzymes such as Sirtuins
(SIRT). Among them, SIRT1 is of particular interest as
beyond its role as deacetylase of proteins involved in DNA
repair pathways (Luna et al., 2013; Fang et al., 2016), it
also deacetylates PGC1α which is a master transcriptional
regulator of several mitochondrial biogenesis genes. Fang et al.
(2016) found that reduced SIRT1 activity in XPA disease
models resulted in diminished expression of the mitochondrial
uncoupling protein 2 (UCP2), a transcriptional target of PGC1α
responsible for mitochondrial hyperpolarization and increased
import, cleavage and removal of PINK1. The in vivo relevance
of these findings is highlighted by the observation that XPA,
CS and AT patients as well as nematode (Caenorhabditis
elegans) and rodent models of XPA possess dysfunctional
mitochondria that contribute to the neurological and other
pathologies manifested in these diseases (Scheibye-Knudsen
et al., 2012; Valentin-Vega et al., 2012; Fang et al., 2014).
Agents that recover NAD+ levels may thus represent a novel
approach for therapeutic intervention in XPA, CS, and AT
disease.
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Overall, there is robust evidence that autophagy is activated by
DDR pathways at multiple levels, raising the important question
of whether autophagy impinges on functional outcomes of DDR.
FUNCTIONAL OUTCOMES OF THE
DDR – AUTOPHAGY AXIS
DNA Damage Repair
One of the most fascinating functional outcomes of the DDR-
autophagy axis is the regulation of DNA damage repair with
major implications in genomic stability, aging and aging-related
pathologies including cancer. Indeed, there is now significant
evidence to suggest that autophagy is required for the function
of ‘error-proof ’ HR and NER (Liu et al., 2015; Park et al.,
2015; Hewitt et al., 2016; Qiang et al., 2016; Wang et al., 2016).
Conversely, autophagy-deficient cells rely mostly on the error-
prone NHEJ repair process, which may explain the genomic
instability observed in experimental mouse models with defective
autophagy (Karantza-Wadsworth et al., 2007; Mathew et al.,
2007b) and the observation that in human breast, ovarian and
prostate cancers, beclin-1 is monoallelically deleted (Aita et al.,
1999).
SQSTM1/p62 emerges as an important mediator of the
effects of autophagy on DNA damage repair. This role has
been attributed to a nuclear pool of p62 that accumulates
upon autophagy blockade and binds RNF168, inhibiting its
E3 ubiquitin ligase activity toward histone H2A. The ensued
reduction in chromatin ubiquitination hinders the recruitment of
DNA repair proteins such as BRCA1, RAD51, and RAP80 to sites
of DSBs and impacts on their ability to repair radiation-induced
DNA damage (Wang et al., 2016). RAD51 is also regulated by
SQSTM1/p62 through filamin A which physiologically responds
to DNA damage by recruiting RAD51 to DSBs. Autophagy
impairment increases the interaction of p62 with filamin A,
causing proteasomal degradation of both filamin A and RAD51
(Hewitt et al., 2016). Therefore, nuclear p62 that accrues from
defective autophagy compromises DNA damage repair and
genomic integrity. In line with these findings, nuclear levels and
co-localization of p62 with DNA damage foci have been reported
to increase with aging, underscoring the potential contribution
of this pathway to aging and age-related diseases (Hewitt et al.,
2016).
Autophagy is also responsible for the degradation of another
chromatin component, HP1α. HP1α maintains a condensed
chromatin configuration that hinders the formation of RAD51
nucleoprotein filaments at DSBs. The successful completion
of HR repair requires access of RAD51 to DSBs which is
achieved by RAD6-mediated ubiquitination and autophagy-
mediated degradation of HP1α (Chen et al., 2015).
Chk1, a regulator of DNA damage repair by HR, is another
recently described target of autophagy. One study showed
that loss of (macro)autophagy by ablation of ATG7 leads to
Chk1 ubiquitination and proteasomal degradation which in
turn impairs DNA damage repair by HR (but not NHEJ) and
genomic integrity (Liu et al., 2015). Another study identified
Chk1 as target of CMA. CMA is upregulated in response to
DNA damage inflicted by irradiation or chemotherapy, leading
to lysosomal degradation of Ser345-phosphorylated Chk1 (Park
et al., 2015). In contrast, Ser317-phosphorylated Chk1 which is
the preferred substrate of the proteasome-dependent degradation
of Chk1 remains unaffected by CMA inhibition, raising the
possibility that different autophagy pathways (e.g., CMA vs.
macro-autophagy) may target distinct Chk1 pools. Intriguingly,
nuclear accumulation of Chk1 that ensues from defective CMA
leads to destabilization of the MRN complex involved in
the initial processing of DSBs prior to DNA repair by HR
(Park et al., 2015). Thus, loss of CMA may facilitate genomic
instability through excessive nuclear accumulation of Chk1 and
deregulation of the MRN complex.
There is also evidence that autophagy positively regulates
NER, the primary mechanism of repair of UV-induced lesions,
by modulating the levels of NER-specific damage recognition
proteins XPC, UVRAG, and DDB1/DDB2 (Qiang et al., 2016;
Yang et al., 2016). UVRAG is of particular relevance as it binds
the Beclin-1/Vps34 complex and increases the catalytic activity
of Vps34, therefore acting as an inducer of autophagy (Liang
et al., 2006). UVRAG is upregulated by radiation (Yin et al.,
2011), localizes to photolesions and associates with DDB1 to
promote the assembly and activity of the DDB2–DDB1–Cul4A–
Roc1 ubiquitin ligase complex, leading to XPC recruitment
and NER (Yang et al., 2016). Conversely, autophagy deficiency
has been reported to impair the recruitment of DDB1/2 to
UVB-induced DNA damage sites (Qiang et al., 2016). Impaired
autophagy also leads to both transcriptional suppression of XPC
and reduction in UVB-induced XPC ubiquitination, a process
critical for DNA damage recognition. The in vivo relevance of
these observations is underscored by pharmacological studies
in mice showing that inhibition of autophagy by the chemical
spautin-1 promotes, whereas stimulation of autophagy by
rapamycin reduces UVB-induced tumorigenesis (Qiang et al.,
2016).
Notwithstanding the impact of autophagic pathways on the
turnover of DNA damage repair proteins, autophagy may have
a generic role in DNA repair by regulating the supply of
ATP, NAD+, and dNTPs that are necessary for this process.
For example, repair of DSB requires ATP-dependent chromatin
remodeling (Bao and Shen, 2007) and the unwinding of DNA
by helicases during NER is an ATP-dependent process (de Laat
et al., 1999). NAD+ is necessary for the function of PARP1
which is involved in base-excision repair (de Murcia et al., 1997).
Moreover, a dNTP pool that is required for DNA replication
and repair is maintained by autophagy-mediated degradation of
ribonucleotide reductase subunits (Kumar et al., 2011). Likewise,
autophagy removes nuclear membrane-enclosed chromosome
fragments containing damaged DNA called micronuclei (Rello-
Varona et al., 2012), a process that may also contribute to
maintenance of genomic integrity.
Overall, the reported findings support a prominent role for
autophagy in coordinating the execution of DNA damage repair
and warrant further studies into how different repair mechanisms
are controlled by distinct modes of autophagy and, conversely,
how different autophagic pathways interact to finely balance
distinct DNA repair systems.
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Senescence
Activation of autophagy contributes to DNA damage-induced
senescence. A study by Kang et al. (2015) has recently unveiled a
novel role for selective autophagy in linking DDR to the secretion
of cytokines, chemokines, growth factors and proteases that
collectively formulate the so-called SASP. The regulation of SASP
has attracted significant attention as factors secreted by senescent
cells establish an inflammatory environment that may foster
the initiation and progression of several pathologies, including
aging and aging-related diseases. The work by Kang et al.
(2015) has implicated the transcription factor GATA4, which is
physiologically targeted for degradation by autophagy through
interaction with the autophagy adaptor p62, in SASP regulation.
Specifically, upon irradiation or oncogene-induced senescence,
GATA4 dissociates from p62 and becomes stabilized, causing
induction of TRAF3IP2 and interleukin-1α (IL-1α) expression.
In turn, TRAF3IP2 and IL-1α activate NF-κB which regulates
major SASP components. Interestingly, activation of this GATA4
pathway depends on the DDR kinases ATM and ATR but is
independent of p53 and p16INK4a. Thus, selective autophagy for
GATA4 functions as an anti-senescence mechanism. Conversely,
stimuli that induce senescence activate ATM and ATR to block
p62-dependent autophagic degradation of GATA4, resulting in
NF-κB activation and SASP induction. The in vivo relevance of
these findings is highlighted by the fact that GATA4 accumulates
in tissues of aged mice and humans as well as in various tissues
of irradiated mice and may well contribute to the low level
inflammation that typifies aging and aging-related pathologies
including cancer (Kang et al., 2015). Interestingly, mice lacking
p62 also exhibit an accelerated aging phenotype (Kwon et al.,
2012).
Autophagy may also regulate SASP post-transcriptionally
through spatial coupling to mTOR (Narita et al., 2011).
In cells undergoing H-RasV12-induced senescence, TORC1-
positive lysosomes are recruited at the vicinity of the nucleus,
resulting in de-inhibition of ULK1 at more distal locations
where autophagosomes can form. As autophagosomes mature,
they fuse with TORC1-positive lysosomes, giving rise to a
novel membrane compartment called ‘TOR-Autophagy Spatial
Coupling Compartment’ or TASCC. The flow of amino acids and
other metabolites from autophagolysosomes activates TORC1
and also provides basic building blocks for the synthesis of
SASP components. Indeed, blocking the localization of TORC1
to the TASCC by knocking-down the RAG GTPases, results in
a reduction in the synthesis and secretion of two major SASP
components, IL6 and IL8 (Narita et al., 2011).
In addition to SASP, autophagy may regulate senescence
in a cell-autonomous manner through degradation of nuclear
lamina components. Dou et al showed that in response to
oncogenic stress or chemotherapy-induced DNA damage,
Lamin B1 is exported from the nucleus together with
chromatin domains, interacts with LC3 and undergoes
autophagic degradation (Dou et al., 2015). Interestingly,
oncogenic stress fails to induce Lamin B1 degradation
and senescence when autophagy is impaired. Moreover,
Lamin B1 is not processed by autophagy during starvation.
Collectively, these data suggest that the activation of autophagy
is required but is not sufficient for the establishment of
oncogene-induced senescence and underscore the diversity
of autophagic responses to different signals. As Lamin B1
anchors proteins that participate in NER (Butin-Israeli et al.,
2013) it would be of interest to examine putative links between
nucleophagy and DNA damage repair and their impact on
senescence.
A key regulator of cellular senescence is ARF (Liontos et al.,
2012). Activated oncogenes, oxidative stress and heat shock
can induce the expression of both nucleolar and mitochondria-
localized ARF (smARF) in a positive or a negative manner
(Sideridou et al., 2011; Liontos et al., 2012; Evangelou et al.,
2013; Velimezi et al., 2013; Kotsinas et al., 2014; Sherr et al.,
2016). When overexpressed, smARF interacts with BCL-XL and
decreases its interaction with Beclin-1. As a result, cell lines
overexpressing smARF are more sensitive to the induction of
autophagy and senescence caused by starvation or hydrogen
peroxide (Pimkina et al., 2009). In contrast, expression of
nucleolar ARF does not confer a similar effect (Reef and
Kimchi, 2008). These observations indicate that smARF may
link autophagy to senescence but whether this applies also
in response to DNA damage remains to be determined. It
would also be of interest to identify targets of smARF-mediated
autophagy. In this regard, a recent study has shown that
smARF overexpression depolarizes mitochondria and promotes
mitophagy in a Parkin/PINK1-dependent manner (Grenier et al.,
2014); the relevance of this finding to DNA damage-induced
senescence requires additional studies.
Very recently, a revolutionary hybrid histo/immuno-chemical
method of a biotin-linked Sudan Black-B analog has been
established to assess the senescent status in in vitro and
in vivo biological settings (Evangelou et al., 2016). This method
may constitute an invaluable research tool for the study of
the interplay between the molecular pathways implicated in
autophagy and DNA damage-induced senescence.
Cell Survival and Resistance to
Genotoxic Therapy
Resistance to chemotherapy represents a major clinical problem
for the management of cancer patients. The effects of autophagy
on cell survival versus death have attracted particular attention
in the context of malignancy as they may affect the outcome of
DNA-targeted drug treatments.
As discussed above, autophagy intersects with DDR in
the regulation of DNA damage repair pathways which are
thought to play protective roles in genotoxic cancer therapy.
Indeed, the autophagy inhibitor chloroquine has been shown
to impair DNA damage repair and to increase the cytotoxic
effect of the chemotherapeutic agent carboplatin in breast
cancer stem cells (Liang et al., 2016). Accumulating evidence
indicates that autophagy is exploited by tumor cells to resist
radiation or chemotherapy-induced cell death and that genetic
or pharmacological inhibition of autophagy sensitizes malignant
cells to genotoxic therapy both in vitro and in experimental
mouse models (Amaravadi et al., 2007; Pan et al., 2011;
Chittaranjan et al., 2014; Wang and Wu, 2014; Filippi-Chiela
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et al., 2015; Liang et al., 2016; Piya et al., 2016). In line with this
is the presence of autophagic vacuoles in Saos2 cells (Figure 2),
a p53 null human osteosarcoma cell line, which after prolonged
expression of p21WAF1/Cip1 exhibit enhanced aggressiveness
and chemoresistance by deregulating the replication licensing
machinery causing replication stress and fuelling genomic
instability (Galanos et al., 2016).
These studies have provided the rationale for the clinical
application of autophagy inhibitors in combination with
established anti-cancer therapies (Huang et al., 2016).
Fortuitously, the autophagy inhibitor hydroxychloroquine
(a chloroquine derivative) has been used for many years in the
management of patients with systemic lupus erythematosus,
rheumatoid arthritis and malaria and therefore information
about dosage, safety and side-effects has been available. The
first phase I clinical trials incorporating hydroxychloroquine
to chemo- or radio-therapeutic regimens aim at assessing the
tolerability of the combination treatments, as well as dose and
schedule optimization and are expected to guide subsequent
clinical studies of efficacy (Poklepovic and Gewirtz, 2014).
Whereas as described above, autophagy mediates survival and
drug resistance at low DNA damage levels, excessive lesions that
cannot be repaired may lead to persistent, unrestraint autophagy
which in turn induces a form of cell death termed ‘autophagic cell
death’ (ACD). ACD is morphologically distinct from apoptosis
and necrosis and is characterized by the sequestration of
cytoplasmic materials in autophagosomes (Mathew et al., 2007a;
Kroemer et al., 2009). Therefore, depending on the extent of DNA
damage, autophagy may play a cytoprotective or cytotoxic role
in the determination of cellular fate. The status of the apoptotic
versus autophagic machinery components is likely to contribute
to this outcome.
Regulation of Mediators of the
Immune/Inflammatory Response
There is significant evidence supporting that DDR and immune
response networks functionally interact (Pateras et al., 2015) and
that autophagy participates in the regulation of inflammatory
pathways (Netea-Maier et al., 2016).
Beyond SASP, autophagy may link DDR to the generation
of local and systemic immune responses through the regulation
of the so-called ‘immunogenic cell death,’ a form of cell death
accompanied by the emission of immunostimulatory DAMPs.
These include cell surface-exposed calreticulin and ATP and
HMGB1 that are released by dying tumor cells following
their exposure to certain genotoxic agents such as ionizing
radiation (IR), doxorubicin and oxaliplatin (Kepp et al., 2014).
A study by Guido Kroemer’s group has shown that autophagy
is critically required for the release of ATP by irradiated tumor
cells (Michaud et al., 2011). In turn, ATP stimulates the P2X7
receptor on antigen-presenting cells (APCs) leading to activation
of the inflammasome, a large multiprotein signaling complex
that regulates the processing of inactive pro-IL-1β to mature,
secretable IL-1β (Michaud et al., 2011).
Intriguingly, autophagy also operates in APCs in a cell-
intrinsic manner to control secretion of IL-1β and other
cytokines. Thus, basal autophagy inhibits IL-1β secretion by
degrading both inflammasome proteins (Shi et al., 2012) and
pro-IL-1β (Harris et al., 2011). In contrast, under conditions of
dual inflammasome and autophagy activation, IL-1β secretion
increases through a non-canonical secretory pathway that
depends on autophagy components (Dupont et al., 2011).
Whereas these studies have not addressed the impact of
autophagy on IL-1β biogenesis and secretion in response to
genotoxic stress, it is likely that autophagy has a broader role in
FIGURE 2 | Electron micrographs of Saos2 p21WAF1/Cip1 Tet-ON human osteosarcoma cells after prolonged p21 overexpression (25 days) evading
senescence and exhibiting aggressiveness and chemoresistance (Galanos et al., 2016). In the cytoplasm of these cells, several autophagic vacuoles were
observed at different stages of autophagic process, i.e., initial autophagic vacuoles (AVi) (A) and degradative autophagic vacuoles (AVd) (A,B), indicating that
autophagy may support the chemoresistant features of these cells. Percentage quantitative analysis showed increased number of autophagic vacuoles in Saos2
p21WAF1/Cip1 Tet-ON cells after prolonged p21 overexpression (30.1 ± 4.3) compared to control cells (without p21 induction) (3.3 ± 0.7). N, nucleus; n, nucleolus; G,
Golgi apparatus.
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influencing the extent and duration of inflammation. This may
be of particular relevance to and warrants further investigations
in aging which is typified in humans by chronic, low-level
inflammation, termed ‘inflammaging’ (Franceschi and Campisi,
2014), accumulated genomic damage (Ribezzo et al., 2016) and
reduced autophagic activity (Martinez-Lopez et al., 2015).
SUMMARY AND PERSPECTIVES
The DDR has been conserved during evolution from bacteria
to mammals, serving pivotal cellular functions that include
repair of DNA lesions and maintenance of DNA integrity.
As prokaryotic cells do not possess lysosomes, autophagy
must have originated at a later phase of evolution than the
DDR. Indeed, despite some differences in the biochemical
pathways involved, autophagy-specific machineries have
been identified in all eukaryotes examined, including yeast,
plants (Arabidopsis thaliana), amoebozoa (Dictyostelium
discoideum), and metazoa (Caenorhabditis elegans, Drosophila
melanogaster, Mus musculus, and Homo sapiens) but not
in prokaryotes (Hughes and Rusten, 2007). It has been
proposed that the original function of autophagy may have
been the adaptation to conditions of starvation through
the recycling of intracellular components, and/or an early
form of innate immune system allowing the destruction
of intracellular bacterial pathogens (Hughes and Rusten,
2007).
However, emerging evidence links autophagy also to the
DDR. Herein we have reviewed this evidence and highlighted
in particular that: (1) autophagy is activated upon exposure to
diverse DNA damaging factors including radiation, chemicals,
ROS and oncogenes; (2) the DDR-autophagy link operates
in a variety of eukaryotic cell types representing different
evolutionary and developmental stages; (3) autophagy is required
for several fundamental processes associated with the cellular
response to DNA damage such as repair of DNA lesions,
senescence, cell death, and cytokine secretion; (4) reduced
autophagic flux characterizes human pathologies that are
associated with accumulation of DNA damage, including cancer
and aging.
Together, these observations raise the possibility that
autophagy may have evolved as a quality control system
that responds to a wide range of stress conditions including
DNA damage, a major cellular stress factor. Unlike the more
broadly conserved ubiquitin-proteasome system which regulates
the turnover of short-lived proteins in both prokaryotes and
eukaryotes, autophagy can target organelles or bulk cytoplasmic
and nuclear material for lysosomal degradation. This is a
property relevant to DDR in eukaryotic cells that enables
them, for example, to deplete mitochondria bearing irreparable
DNA damage and to control the number of mitochondria
under stress conditions. Notably, the autophagic degradation
of dysfunctional mitochondria (mitophagy) operates across
the Eukaryota domain, including yeast, nematodes, flies, and
mammals (Hirota et al., 2012), contributes to lifespan extension
in model organisms (Palikaras et al., 2015) and protects against
aging-related pathologies such as cancer and neurodegenerative
diseases (Mathew et al., 2007a; Menzies et al., 2015; Fang et al.,
2016). Further studies are needed to address the impact of DDR
signaling on autophagy-mediated degradation of organelles other
than mitochondria and their role in aging and aging-related
disease pathogenesis. For example, defects in autophagy-
mediated lipid droplet degradation (lipophagy) have been
associated with metabolic disease and liver steatosis (Madrigal-
Matute and Cuervo, 2016) but whether DDR utilizes this
degradation pathway remains largely unexplored. Intriguingly,
systemic DNA damage ensued by NER deficiency in mouse
adipocytes leads to destruction of white adipose tissue depots
(Karakasilioti et al., 2013). Whilst the contribution of autophagic
degradation of lipid droplets to this phenotype remains elusive,
the aforementioned observation does raise the possibility of
putative links between DDR and lipophagy.
The exciting findings that continue to emerge in this field
warrant further studies into the complex and often contrasting
roles of autophagy in the onset, progression and therapy of
various human diseases. This need is underscored by its dual role
in malignancy: whereas autophagy prevents genomic instability,
a hallmark of cancer, it may promote survival of tumor cells
under stress conditions, including those induced by anticancer
therapy (Mathew et al., 2007a). As the pathological basis of the
vast majority of human diseases is typified by the involvement
of multiple cell types and inter-organ communication, further
studies are needed to address how tissue-specific deregulation
of the DDR-autophagy axis may lead to systemic effects
underpinning disease pathogenesis. Along these lines, a recently
published study revealed a mechanism by which autophagy in
the CNS and periphery coordinate lipophagy in the liver and
adipose tissue (Martinez-Lopez et al., 2016). Likewise, the pursuit
of autophagic pathways and their functional outcomes will no
doubt continue to provide an invaluable side entrance into the
complex but fascinating biology of DDR.
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